Thursday, June 1, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
The Samuel Rahbar Endowed Chair in Diabetes & Drug Discovery
Chair and Professor, Department of Diabetes Immunology
Director, The Wanek Family Project for Type 1 Diabetes
Arthur Riggs Diabetes & Metabolism Research Institute
City of Hope
Duarte, California, United States
Professor of Clinical Diabetes and Metabolism
Director of the Joint Research Office
Cardiff & Vale Health Board and Cardiff University
Senior Clinical Researcher
Wellcome Centre for Human Genetics
University of Oxford
Oxford, England
American Diabetes Association Eminent Scholar for Diabetes Research
Jeffrey Keene Family Professor
Director, UF Diabetes Institute
Departments of Pathology and Pediatrics
The University of Florida
Gainesville, Florida, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
This activity is intended for pediatric endocrinologists, diabetologists/endocrinologists, pediatricians, primary care physicians, and other clinicians who care for patients with or at risk for T1D.
The goal of this activity is for learners to be better able to describe how anti-CD3 monoclonal antibodies can delay/prevent clinical T1D in patients at risk of developing the disease.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
The Samuel Rahbar Endowed Chair in Diabetes & Drug Discovery
Chair and Professor, Department of Diabetes Immunology
Director, The Wanek Family Project for Type 1 Diabetes
Arthur Riggs Diabetes & Metabolism Research Institute
City of Hope
Duarte, California, United States
Professor of Clinical Diabetes and Metabolism
Director of the Joint Research Office
Cardiff & Vale Health Board and Cardiff University
Senior Clinical Researcher
Wellcome Centre for Human Genetics
University of Oxford
Oxford, England
American Diabetes Association Eminent Scholar for Diabetes Research
Jeffrey Keene Family Professor
Director, UF Diabetes Institute
Departments of Pathology and Pediatrics
The University of Florida
Gainesville, Florida, United States
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC Released: 5/24/2023
Valid for credit through: 5/24/2024
processing....
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
